Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;59(6):890-892.
doi: 10.1038/s41409-024-02242-1. Epub 2024 Mar 8.

Von Willebrand factor as a potential predictive biomarker of early complications of endothelial origin after allogeneic hematopoietic stem cell transplantation

Guillaume Dachy  1 , Marine Vankeerbergen  2 , Nicolas Vanlangendonck  2 , Nicole Straetmans  2 , Catherine Lambert  2 , Cédric Hermans  2 , Xavier Poiré  2
Affiliations

Von Willebrand factor as a potential predictive biomarker of early complications of endothelial origin after allogeneic hematopoietic stem cell transplantation

Guillaume Dachy et al. Bone Marrow Transplant. 2024 Jun.
No abstract available

PubMed Disclaimer

References

    1. Pagliuca S, Michonneau D, Sicre de Fontbrune F, Sutra Del Galy A, Xhaard A, Robin M, et al. Allogeneic reactivity-mediated endothelial cell complications after HSCT: a plea for consensual definitions. Blood Adv. 2019;3:2424–35. https://doi.org/10.1182/bloodadvances.2019000143 . - DOI - PubMed - PMC
    1. Fraebel J, Engelhardt BG, Kim TK. Noninfectious pulmonary complications after hematopoietic stem cell transplantation. Transpl Cell Ther. 2023;29:82–93. https://doi.org/10.1016/j.jtct.2022.11.012 . - DOI
    1. Elsawy M, Sorror ML. Up-to-date tools for risk assessment before allogeneic hematopoietic cell transplantation. Bone Marrow Transpl. 2016;51:1283–1300. https://doi.org/10.1038/bmt.2016.141 . - DOI
    1. Sorror ML, Sandmaier BM, Storer BE, Maris MB, Baron F, Maloney DG, et al. Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation. J Clin Oncol. 2007;25:4246–54. https://doi.org/10.1200/JCO.2006.09.7865 . - DOI - PubMed
    1. Luft T, Benner A, Terzer T, Jodele S, Dandoy CE, Storb R, et al. EASIX and mortality after allogeneic stem cell transplantation. Bone Marrow Transpl. 2020;55:553–61. https://doi.org/10.1038/s41409-019-0703-1 . - DOI

LinkOut - more resources